Us Congress 2025-2026 Regular Session

House Energy and Commerce Committee Bills & Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2851

Introduced
4/10/25  
WISE Act Working for Immigrant Safety and Empowerment Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1189

Introduced
2/11/25  
National Plan for Epilepsy Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1184

Stop China’s Continuous Purchase of Land Act or the Stop CCP Land ActThis bill requires states that receive certain federal program funds to restrict the purchase of agricultural land by a covered foreign country. Covered foreign country means a country included in Department of State regulations as subject to certain prohibitions (i.e., Belarus, Burma, China, Cuba, Iran, North Korea, Syria, and Venezuela), as well as Russia.Specifically, a state may not receive funds for certain programs funded by the Inflation Reduction Act of 2022 (e.g., certain energy efficiency and conservation programs) unless that state has a law prohibiting a covered foreign country (or persons acting on behalf of the country) from purchasing agricultural land in the state. Further, a state must require that a person from a covered foreign country that holds agricultural land in the state prior to the state law's enactment submit an annual report to the state on the agricultural holdings.The Department of Agriculture must submit a report to Congress on how the Agricultural Foreign Investment Disclosure Act of 1978 should be updated to ensure accurate documentation and monitoring of foreign investment in agricultural land.The Government Accountability Office must submit a report to Congress that includes (1) an assessment of this bill's impact on national security, and (2) any measures that can be taken to better secure U.S. real estate from foreign manipulation. 
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1185

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1149

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1143

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1126

Introduced
2/7/25  
East Palestine Health Impact Monitoring Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1108

Introduced
2/7/25  
Diagnostics Testing Preparedness Plan Act of 2025This bill requires the Department of Health and Human Services (HHS) to develop and publish a plan for the rapid development and distribution of diagnostic tests in response to a chemical, biological, radiological, or nuclear threat, including an emerging infectious disease, that causes or has significant potential to cause a declared public health emergency.Specifically, HHS must coordinate with any relevant public and private entities, such as government entities and device manufacturers, in creating the plan and facilitating its collaborative implementation. The plan must take into consideration certain factors specified in the bill, including domestic testing capacity, novel technologies, and medical supply needs. HHS must publish the plan within one year after enactment of the bill and then update the plan every three years.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1142

Introduced
2/7/25  
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1064

Introduced
2/6/25  
Stopping Overdoses of Fentanyl Analogues ActThis bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires March 31, 2025.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1100

Introduced
2/6/25  
STOPP Act Stop the Opioid Pill Presser and Fentanyl Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1060

Introduced
2/6/25  
Modern Authentication of Pharmaceuticals Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB925

Introduced
2/4/25  
To ensure equal protection of the law, to prevent racism in the Federal Government, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB795

Introduced
1/28/25  
Pregnancy Is Not an Illness Act of 2025This bill prohibits the Food and Drug Administration (FDA) from treating pregnancy as an illness for the purposes of approving any abortion drug or imposing a risk evaluation and mitigation strategy for an abortion drug. The bill also nullifies FDA approval of any abortion drug that relied at all on the treatment of pregnancy as an illness, and specifically nullifies the FDA’s approval of the abortion drug mifepristone in effect before the bill is enacted.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB798

Introduced
1/28/25  
Dignity for Aborted Children ActThis bill establishes requirements for abortion providers with respect to the disposal of human fetal tissue from an abortion.Specifically, it requires abortion providers to obtain a patient's informed consent for one of two specified methods of disposition and to retain the corresponding documentation in the patient's file.First, patients may choose to retain possession of the tissue. A patient may choose to transfer the tissue to an entity that provides interment or cremation services.Second, patients may choose to release the tissue to the provider. Providers must ensure any tissue released to them is interred or cremated within seven days of the procedure in a manner consistent with state law regarding the disposal of human remains.Abortion providers must submit reports annually to the Department of Health and Human Services about these requirements and other specified information.The bill establishes civil penalties for violations of the requirement to retain documentation of informed consent, and it establishes criminal penalties for violations of the requirement regarding the disposal of human fetal tissue.